IIT Bombay Team Develops Affordable Tinnitus Diagnosis And Management Device
Researchers from IIT Bombay have developed precise tinnitus matching device and customizable solution (Mobile based software) at an affordable cost. Tinnitus is the perception of sound in the absence of any external stimulus.
As per the research data published in JAMA neurology 2022, Tinnitus affects more than 740 million adults globally and is considered to be a major problem faced by more than 120 million people.
Tinnitus results in severe sleep disturbance, depression, anxiety, negative impact on mental health, irritability, impacting social life. Overall tinnitus has a demoralizing impact on the quality of life.
The team of researchers Prof. Maryam Shojaei Baghini, Mr. Neeleshkumar Pandit, and a group of M. Tech students along with a team of medical experts Dr. Milind Kirtane, Dr. Arpit Sharma, Dr. Sangeeta Varty and Ms. Nishita Mohandas from Hindjuja Hospital, Mumbai worked on the design, development and the clinical evaluation of innovation in tinnitus diagnosis and its customizable management. The project has received funding from TCTD, IIT Bombay and WRCB, IIT Bombay.
Also Read: IIT Kanpur’s Class Of 1999 Pledges Rs 11.6 Crore At Silver Jubilee Reunion
The clinical evaluation demonstrated improvement in the tinnitus symptoms for the subjects enrolled in the clinical trial.
The device and the supporting application software offers a comprehensive approach that includes precise tinnitus matching, customizable multimodal tinnitus management approach and diseases progress tracking at an affordable cost. The objective of the project is to equip clinicians with the precise tinnitus diagnosis tools and provide each patient a unique experience in the tinnitus management.
The key features of innovation are as follows:
- Precise tinnitus matching device for diagnosis
- Customizable multimodal tinnitus management software for the patient that is IoT and IoMT enabled at the clinic level.
- Indigenous and affordable
The technology is being transferred to the start-up formed out of the project. The start-up team plans to expand clinical trials and work on the regulatory approval for the product’s commercialization.
Also Read: UGC-NET December 2024 Admit Card Released
The device, software and results of the first clinical trial were reported in the peerreviewed International Journal of Clinical Skills December 2024.
